HEADER TRANSFERASE/TRANSFERASE INHIBITOR 06-MAY-11 3RVG TITLE CRYSTALS STRUCTURE OF JAK2 WITH A 1-AMINO-5H-PYRIDO[4,3-B]INDOL-4- TITLE 2 CARBOXAMIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 835-1132; COMPND 5 SYNONYM: JANUS KINASE 2, JAK-2; COMPND 6 EC: 2.7.1.112, 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS TYROSINE KINASE, JANUS KINASE 2, ENZYME INHIBITORS, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.LIM,B.TAOKA,R.D.OTTE,K.SPENCER,C.J.DINSMORE,M.D.ALTMAN,G.CHAN, AUTHOR 2 C.ROSENSTEIN,S.SHARMA,H.P.SU,A.A.SZEWCZAK,L.XU,H.YIN,J.ZUGAY-MURPHY, AUTHOR 3 C.G.MARSHALL,J.R.YOUNG REVDAT 2 08-NOV-17 3RVG 1 REMARK REVDAT 1 21-MAR-12 3RVG 0 JRNL AUTH J.LIM,B.TAOKA,R.D.OTTE,K.SPENCER,C.J.DINSMORE,M.D.ALTMAN, JRNL AUTH 2 G.CHAN,C.ROSENSTEIN,S.SHARMA,H.P.SU,A.A.SZEWCZAK,L.XU,H.YIN, JRNL AUTH 3 J.ZUGAY-MURPHY,C.G.MARSHALL,J.R.YOUNG JRNL TITL DISCOVERY OF 1-AMINO-5H-PYRIDO[4,3-B]INDOL-4-CARBOXAMIDE JRNL TITL 2 INHIBITORS OF JANUS KINASE 2 (JAK2) FOR THE TREATMENT OF JRNL TITL 3 MYELOPROLIFERATIVE DISORDERS. JRNL REF J.MED.CHEM. V. 54 7334 2011 JRNL REFN ISSN 0022-2623 JRNL PMID 21942426 JRNL DOI 10.1021/JM200909U REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.6.4_486 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.63 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 11558 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.225 REMARK 3 R VALUE (WORKING SET) : 0.221 REMARK 3 FREE R VALUE : 0.300 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.240 REMARK 3 FREE R VALUE TEST SET COUNT : 606 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 31.6345 - 3.9634 1.00 2814 159 0.2019 0.2725 REMARK 3 2 3.9634 - 3.1468 1.00 2749 137 0.2118 0.3002 REMARK 3 3 3.1468 - 2.7493 1.00 2698 159 0.2442 0.3265 REMARK 3 4 2.7493 - 2.4980 0.99 2689 151 0.2918 0.3709 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.00 REMARK 3 SHRINKAGE RADIUS : 0.72 REMARK 3 K_SOL : 0.31 REMARK 3 B_SOL : 30.59 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.450 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.790 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 43.14 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.11120 REMARK 3 B22 (A**2) : 0.11120 REMARK 3 B33 (A**2) : -0.22240 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2447 REMARK 3 ANGLE : 1.231 3301 REMARK 3 CHIRALITY : 0.075 343 REMARK 3 PLANARITY : 0.005 418 REMARK 3 DIHEDRAL : 18.150 926 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3RVG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-JUN-11. REMARK 100 THE DEPOSITION ID IS D_1000065425. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-MAR-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11558 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES PH 7.5, 100MM AMMONIUM REMARK 280 SULFATE, 33.5% PEG 3350, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 24.48933 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 12.24467 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 18.36700 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 6.12233 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 30.61167 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 834 REMARK 465 ALA A 835 REMARK 465 PHE A 836 REMARK 465 GLU A 837 REMARK 465 ASP A 838 REMARK 465 ARG A 839 REMARK 465 ASP A 840 REMARK 465 LYS A 1011 REMARK 465 GLU A 1012 REMARK 465 PRO A 1013 REMARK 465 GLY A 1014 REMARK 465 GLU A 1015 REMARK 465 LEU A 1133 REMARK 465 VAL A 1134 REMARK 465 PRO A 1135 REMARK 465 ARG A 1136 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 859 CG OD1 ND2 REMARK 470 LYS A1069 CG CD CE NZ REMARK 470 GLN A1070 CB CG CD OE1 NE2 REMARK 470 GLN A1072 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 852 -61.15 -129.43 REMARK 500 ASN A 859 -70.33 -42.38 REMARK 500 LEU A 925 121.50 47.73 REMARK 500 ARG A 975 -7.61 76.84 REMARK 500 ASP A 976 29.18 -141.54 REMARK 500 PHE A 995 33.28 -143.43 REMARK 500 LYS A1005 150.86 -47.40 REMARK 500 ASP A1068 -18.16 -164.10 REMARK 500 GLN A1070 -135.28 -77.53 REMARK 500 ALA A1131 -30.72 -136.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 17P A 2000 DBREF 3RVG A 835 1132 UNP O60674 JAK2_HUMAN 835 1132 SEQADV 3RVG MET A 834 UNP O60674 EXPRESSION TAG SEQADV 3RVG LEU A 1133 UNP O60674 EXPRESSION TAG SEQADV 3RVG VAL A 1134 UNP O60674 EXPRESSION TAG SEQADV 3RVG PRO A 1135 UNP O60674 EXPRESSION TAG SEQADV 3RVG ARG A 1136 UNP O60674 EXPRESSION TAG SEQRES 1 A 303 MET ALA PHE GLU ASP ARG ASP PRO THR GLN PHE GLU GLU SEQRES 2 A 303 ARG HIS LEU LYS PHE LEU GLN GLN LEU GLY LYS GLY ASN SEQRES 3 A 303 PHE GLY SER VAL GLU MET CYS ARG TYR ASP PRO LEU GLN SEQRES 4 A 303 ASP ASN THR GLY GLU VAL VAL ALA VAL LYS LYS LEU GLN SEQRES 5 A 303 HIS SER THR GLU GLU HIS LEU ARG ASP PHE GLU ARG GLU SEQRES 6 A 303 ILE GLU ILE LEU LYS SER LEU GLN HIS ASP ASN ILE VAL SEQRES 7 A 303 LYS TYR LYS GLY VAL CYS TYR SER ALA GLY ARG ARG ASN SEQRES 8 A 303 LEU LYS LEU ILE MET GLU TYR LEU PRO TYR GLY SER LEU SEQRES 9 A 303 ARG ASP TYR LEU GLN LYS HIS LYS GLU ARG ILE ASP HIS SEQRES 10 A 303 ILE LYS LEU LEU GLN TYR THR SER GLN ILE CYS LYS GLY SEQRES 11 A 303 MET GLU TYR LEU GLY THR LYS ARG TYR ILE HIS ARG ASP SEQRES 12 A 303 LEU ALA THR ARG ASN ILE LEU VAL GLU ASN GLU ASN ARG SEQRES 13 A 303 VAL LYS ILE GLY ASP PHE GLY LEU THR LYS VAL LEU PRO SEQRES 14 A 303 GLN ASP LYS GLU PTR PTR LYS VAL LYS GLU PRO GLY GLU SEQRES 15 A 303 SER PRO ILE PHE TRP TYR ALA PRO GLU SER LEU THR GLU SEQRES 16 A 303 SER LYS PHE SER VAL ALA SER ASP VAL TRP SER PHE GLY SEQRES 17 A 303 VAL VAL LEU TYR GLU LEU PHE THR TYR ILE GLU LYS SER SEQRES 18 A 303 LYS SER PRO PRO ALA GLU PHE MET ARG MET ILE GLY ASN SEQRES 19 A 303 ASP LYS GLN GLY GLN MET ILE VAL PHE HIS LEU ILE GLU SEQRES 20 A 303 LEU LEU LYS ASN ASN GLY ARG LEU PRO ARG PRO ASP GLY SEQRES 21 A 303 CYS PRO ASP GLU ILE TYR MET ILE MET THR GLU CYS TRP SEQRES 22 A 303 ASN ASN ASN VAL ASN GLN ARG PRO SER PHE ARG ASP LEU SEQRES 23 A 303 ALA LEU ARG VAL ASP GLN ILE ARG ASP ASN MET ALA GLY SEQRES 24 A 303 LEU VAL PRO ARG MODRES 3RVG PTR A 1007 TYR O-PHOSPHOTYROSINE MODRES 3RVG PTR A 1008 TYR O-PHOSPHOTYROSINE HET PTR A1007 16 HET PTR A1008 16 HET 17P A2000 29 HETNAM PTR O-PHOSPHOTYROSINE HETNAM 17P 1-(CYCLOHEXYLAMINO)-7-(1-METHYL-1H-PYRAZOL-4-YL)-5H- HETNAM 2 17P PYRIDO[4,3-B]INDOLE-4-CARBOXAMIDE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 2 17P C22 H24 N6 O FORMUL 3 HOH *7(H2 O) HELIX 1 1 GLU A 845 ARG A 847 5 3 HELIX 2 2 THR A 888 SER A 904 1 17 HELIX 3 3 SER A 919 ARG A 923 5 5 HELIX 4 4 SER A 936 HIS A 944 1 9 HELIX 5 5 LYS A 945 ILE A 948 5 4 HELIX 6 6 ASP A 949 LYS A 970 1 22 HELIX 7 7 PRO A 1017 TYR A 1021 5 5 HELIX 8 8 ALA A 1022 SER A 1029 1 8 HELIX 9 9 SER A 1032 THR A 1049 1 18 HELIX 10 10 SER A 1056 GLY A 1066 1 11 HELIX 11 11 GLN A 1072 ASN A 1084 1 13 HELIX 12 12 PRO A 1095 TRP A 1106 1 12 HELIX 13 13 ASN A 1109 ARG A 1113 5 5 HELIX 14 14 SER A 1115 MET A 1130 1 16 SHEET 1 A 5 LEU A 849 LYS A 857 0 SHEET 2 A 5 GLY A 861 TYR A 868 -1 O VAL A 863 N LEU A 855 SHEET 3 A 5 GLU A 877 LEU A 884 -1 O VAL A 879 N CYS A 866 SHEET 4 A 5 LYS A 926 GLU A 930 -1 O LEU A 927 N LYS A 882 SHEET 5 A 5 TYR A 913 CYS A 917 -1 N LYS A 914 O ILE A 928 SHEET 1 B 2 TYR A 972 ILE A 973 0 SHEET 2 B 2 LYS A 999 VAL A1000 -1 O LYS A 999 N ILE A 973 SHEET 1 C 2 ILE A 982 ASN A 986 0 SHEET 2 C 2 ARG A 989 ILE A 992 -1 O LYS A 991 N LEU A 983 SHEET 1 D 2 PTR A1008 LYS A1009 0 SHEET 2 D 2 LYS A1030 PHE A1031 -1 O PHE A1031 N PTR A1008 LINK C GLU A1006 N PTR A1007 1555 1555 1.33 LINK C PTR A1007 N PTR A1008 1555 1555 1.33 LINK C PTR A1008 N LYS A1009 1555 1555 1.33 SITE 1 AC1 10 LEU A 855 ALA A 880 GLU A 930 TYR A 931 SITE 2 AC1 10 LEU A 932 PRO A 933 GLY A 935 LEU A 983 SITE 3 AC1 10 ILE A1065 HIS A1077 CRYST1 124.433 124.433 36.734 90.00 90.00 120.00 P 65 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008036 0.004640 0.000000 0.00000 SCALE2 0.000000 0.009280 0.000000 0.00000 SCALE3 0.000000 0.000000 0.027223 0.00000